BrightPath Biotherapeutics Co., Ltd.(4594) News
-
BrightPath Biotherapeutics, The Current Fiscal Year's Net Income to Widen
Thu May 14, 2026 3:32 pm JST Earnings -
BrightPath Biotherapeutics, Net Income Forecast for the Fiscal Year Loss Widened in Downward Revision
Fri Mar 13, 2026 3:30 pm JST Revision -
BrightPath Biotherapeutics, Apr-Dec (Cumulative 3Q) Net Income Loss Widens, Oct-Dec Net Income Loss Widens
Fri Feb 13, 2026 3:32 pm JST Earnings -
BrightPath Biotherapeutics, First Half Net Income Loss Narrows, Jul-Sep Net Income Loss Widens
Fri Nov 14, 2025 3:32 pm JST Earnings -
BrightPath Biotherapeutics, Apr-Jun (1Q) Net Income Loss Narrows
Fri Aug 8, 2025 3:30 pm JST Earnings -
U.S. FDA Orphan Drug Designation Granted to BP2202 for the Treatment of Multiple Myeloma
Thu Jul 3, 2025 3:30 pm JST Disclosures(EN) -
BrightPath Presented Data on Bispecific Antibody BP1212 for Cancer Therapy at IRCI 2025
Thu Jun 19, 2025 8:00 pm JST Disclosures(EN) -
Brightpath to Present Data on Bispecific Antibody BP1212 for Cancer Immunotherapy at IRCI 2025
Fri Jun 13, 2025 5:30 pm JST Disclosures(EN) -
BrightPath Biotherapeutics, Continue Net Income Turns to Loss
Fri May 9, 2025 3:30 pm JST Earnings -
BrightPath Biotherapeutics, The Current Fiscal Year Net Income Loss Widened in Downward Revision
Mon Mar 24, 2025 6:00 pm JST Revision -
BrightPath Biotherapeutics, Apr-Dec (Cumulative 3Q) Net Income Loss Narrows, Oct-Dec Net Income Loss Narrows
Fri Feb 14, 2025 3:30 pm JST Earnings -
BrightPath Biotherapeutics Co., Ltd., First Half Net Income Loss Narrows, July-September Net Income Loss Narrows
Fri Nov 8, 2024 3:30 pm JST Earnings